Photodynamic therapy has shown promise in the treatment of early head and neck squamous cell carcinoma (SCC). In photodynamic therapy (PDT), a light sensitive drug (photosensitizer) and visible light cause cancer cell death by the creation of singlet oxygen and free radicals, inciting an immune response, and vascular collapse. In this paper, we review several studies that demonstrate the effectiveness of PDT in the treatment of early stage SCC of the head and neck, with some showing a similar response rate to surgery. Two cases are presented to illustrate the effectiveness of PDT. Then, new advances are discussed including the discovery of STAT3 crosslinking as a potential biomarker for PDT response and interstitial PDT for locally advanced cancers.
Recent advances in interventional pulmonology led to a significant expansion of the diagnostic and therapeutic role of endobronchial ultrasound. In this paper, we describe a new concept for using endobronchial ultrasound to guide interstitial photodynamic therapy (PDT). For this purpose, we conducted in vitro and in vivo experiments using a phantom and animal models, respectively. A new 0.5 mm optical fiber, with cylindrical diffuser end, was used to deliver the therapeutic light through the 21-gauge endobronchial ultrasound needle. The animal experiments were performed under real-time ultrasonography guidance in mice and rabbits’ tumor models. Safe and effective fiber placements and tumor illumination was accomplished. In addition, computer simulation of light propagation suggests that locally advanced lung cancer tumor can be illuminated. This study demonstrates the potential feasibility of this new therapeutic modality approach, justifying further investigation in the treatment of locally advanced lung cancers.
Chemical biopsy by solid‐phase microextraction (SPME) with sorbent‐coated fibers offers monitoring of biological processes in a significantly less invasive manner compared to conventional tissue biopsy. The developed device features a self‐protective design by using an acupuncture needle coated with biocompatible material only in a recessed section. The coating comprises micron‐sized naturally wettable sorbent particles embedded in a durable, biocompatible binder, ensuring broad analyte extraction coverage without the need for solvent activation. This design allows professionals in biochemical research and medical staff to use the device for in vivo monitoring of tissue concentrations of endogenous and/or exogenous substances without introducing activation solvent to the investigated system. The device is successfully used to sample anti‐cancer drugs in both animal models and human patients undergoing in vivo lung perfusion (IVLP) surgery, and then determine the drug concentration level by LC/MS. Finally, a proof‐of‐concept experiment using a microfluidic open interface (MOI) to directly desorb and introduce the extract analytes from the coating to MS detection is proposed for potential on‐site real‐time drug monitoring during the surgery.
1 August 2006 in Otolaryngology–Head and Neck Surgery